A study released by the American Epilepsy Society (AES) confirms CBD may be effective in combating epilepsy. Many parents turned to CBD (Cannabidiol) after exhausting other treatment options with negative side effects or nominal results.
At first, administering “Marijuana” to kids stirred up a lot of controversies. Because CBD (Cannabidiol) has no psychoactive properties and its effects are exclusively beneficial, more parents have been open to giving it to their children.
It’s been reported that various seizure medications leave epileptic children in a fog, as opposed to the clarity that CBD gives.
While clinical trials are still underway to confirm the effectiveness of CBD oil treatment for seizures, many epileptic patients along with parents of epileptic children have reported many miraculous benefits of CBD.
1981 – The anticonvulsant nature of cannabidiol suggests that it has a therapeutic potential in at least three of the four major types of epilepsy
1981 – Seven out of the eight epileptics receiving cannabidiol had improvement of their disease state, whereas only one placebo patient improved.
2010 – Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
2012 – Study finds that evidence strongly supports CBD as a therapeutic candidate for a diverse range of human epilepsies.
2017 – One study suggests that Cannabidiol (CBD) may be well tolerated as an adjunctive medication for seizure management and provides initial data supporting further study of cannabidiol in individuals with Sturge-Weber syndrome.
- CBD for children with Dravet’s and intractable seizures (Video)
- Report of a parent survey of CBD-enriched cannabis use in pediatric treatment-resistant epilepsy
- Medicinal marijuana stops seizures, brings hope to a little girl
- Cannabinoids for epilepsy
- Cannabis, CBD, and epilepsy – From receptors to clinical response
- The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability
- Chronic administration of CBD to healthy volunteers and epileptic patients
- Endocannabinoid system protects against cryptogenic seizures
- Seizing an opportunity for the endocannabinoid system
- Cannabidiol: promise and pitfalls
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- From the Editors: Cannabidiol and medical marijuana for the treatment of epilepsy
- Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
- CBD exerts anti-convulsant effects in animal models of the temporal lobe and partial seizures
- Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
- Hypnotic and antiepileptic effects of CBD
- The cannabinoids as potential antiepileptics
- Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats
- CBD Post-Treatment Alleviates Rat Epileptic-Related Behaviors
- Pharmacology of cannabinoids in the treatment of epilepsy
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
- Report from a Survey of Parents Regarding the Use of Cannabidiol in Mexican Children with Refractory Epilepsy.
- Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
- CBD Treatment for Refractory Seizures in Sturge-Weber Syndrome
- Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?